Rifka C. Schulman-Rosenbaum

Multidisciplinary management of endocrinopathies and treatment‐related toxicities in patients with Bloom syndrome and cancer

Lubaina S. Presswala, Alana Slomovic, Carolyn Fein Levy, 2020, Pediatric blood & cancer.

Assessment of Insulin Infusion Requirements in COVID-19-Infected Patients With Diabetic Ketoacidosis

N. Kohn, T. Calder, Rifka C. Schulman-Rosenbaum, 2022, Endocrine Practice.

Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review

C. C. Low Wang, Cecilia C. Low Wang, J. Lester, 2022, Endocrine Practice.

Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c

Danielle L Brooks, Rifka C. Schulman-Rosenbaum, C. Gordon, 2022, Diabetes Epidemiology and Management.

Use of Endocrine Consultation for HbA1c ≥ 9.0% as a Standardized Practice in an Emergency Department Observation Unit.

R. Silverman, D. Jornsay, Frederick Davis, 2021, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Abstract #1002785: A Case of Bilateral Adrenal Hemorrhage Associated with COVID-19

R. Jaiswal, Rifka C. Schulman-Rosenbaum, 2021, Endocrine Practice.

SGLT2 Inhibitors Should be Avoided for Inpatient Management of Hyperglycemia.

Rifka C. Schulman-Rosenbaum, Benjamin Cohen, Yael Tobi Harris, 2023, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.